GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Double Bond Pharmaceutical International AB (XSAT:DBP B) » Definitions » Cyclically Adjusted PS Ratio

Double Bond Pharmaceutical International AB (XSAT:DBP B) Cyclically Adjusted PS Ratio : (As of Jun. 26, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Double Bond Pharmaceutical International AB Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Double Bond Pharmaceutical International AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Double Bond Pharmaceutical International AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Double Bond Pharmaceutical International AB Cyclically Adjusted PS Ratio Chart

Double Bond Pharmaceutical International AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 19.94

Double Bond Pharmaceutical International AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 19.94 -

Competitive Comparison of Double Bond Pharmaceutical International AB's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Double Bond Pharmaceutical International AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Double Bond Pharmaceutical International AB's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Double Bond Pharmaceutical International AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Double Bond Pharmaceutical International AB's Cyclically Adjusted PS Ratio falls into.


;
;

Double Bond Pharmaceutical International AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Double Bond Pharmaceutical International AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Double Bond Pharmaceutical International AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0/132.8245*132.8245
=0.000

Current CPI (Mar. 2025) = 132.8245.

Double Bond Pharmaceutical International AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.000 99.995 0.000
201509 0.000 100.228 0.000
201512 0.000 100.276 0.000
201603 0.000 100.751 0.000
201606 0.000 101.019 0.000
201609 0.000 101.138 0.000
201612 0.000 102.022 0.000
201703 0.000 102.022 0.000
201706 0.000 102.752 0.000
201709 0.000 103.279 0.000
201712 0.000 103.793 0.000
201803 0.000 103.962 0.000
201806 0.000 104.875 0.000
201809 0.000 105.679 0.000
201812 0.001 105.912 0.001
201903 0.004 105.886 0.005
201906 0.000 106.742 0.000
201909 0.002 107.214 0.002
201912 0.001 107.766 0.001
202003 0.010 106.563 0.012
202006 0.011 107.498 0.014
202009 0.001 107.635 0.001
202012 0.005 108.296 0.006
202103 0.002 108.360 0.002
202106 0.004 108.928 0.005
202109 0.007 110.338 0.008
202112 0.004 112.486 0.005
202203 0.005 114.825 0.006
202206 0.004 118.384 0.004
202209 0.005 122.296 0.005
202212 0.005 126.365 0.005
202303 0.005 127.042 0.005
202306 0.005 129.407 0.005
202309 0.003 130.224 0.003
202312 0.003 131.912 0.003
202403 0.005 132.205 0.005
202406 0.002 132.716 0.002
202409 0.003 132.304 0.003
202412 0.002 132.987 0.002
202503 0.000 132.825 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Double Bond Pharmaceutical International AB  (XSAT:DBP B) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Double Bond Pharmaceutical International AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Double Bond Pharmaceutical International AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Double Bond Pharmaceutical International AB Business Description

Traded in Other Exchanges
N/A
Address
Virdings Alle 32B, Uppsala, SWE, 75450
Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.

Double Bond Pharmaceutical International AB Headlines

No Headlines